DENDRITX LTD
ActiveCompany number 03369238
Cambridge, England · Incorporated 12 May 1997
Hauxton House, Millsciencetech Park,, Mill Lane, Hauxton, Cambridge, CB22 5HX, England
Last updated on 14 September 2026
Research and experimental development on biotechnology · SIC 72110
Other human health activities · SIC 86900
Company history
GINKO BILOBA LIMITED · 12 May 1997 – 14 August 2015
CANCER IMMUNOTHERAPY LTD · 14 August 2015 – 19 May 2026
Company overview
DENDRITX LTD (company number 03369238) is an active private limited company incorporated on 12 May 1997. It is registered at Hauxton House, Millsciencetech Park, Mill Lane, Hauxton, Cambridge CB22 5HX. The company changed its name from GINKO BILOBA LIMITED to CANCER IMMUNOTHERAPY LTD in August 2015, and then to its present name on 19 May 2026.
It is classified under SIC codes 72110 (Research and experimental development on biotechnology) and 86900 (Other human health activities). The company has remained dormant since incorporation, with the most recent set of dormant accounts made up to 31 May 2025. Confirmation statements are filed annually, the latest made up to 12 May 2026.
Current officers are Susanna Mary Colaco and Robert Michael Damms as directors, and Ingeneous Holdings Limited as corporate director. Gillian Pauline Morris resigned as secretary on 9 May 2026. Persons with significant control are Mrs Susanna Mary Colaco (25-50% shares) and Ingeneous Holdings Ltd (50-75% shares).
The company has no charges, no insolvency history, and has never been liquidated.
Compliance
Financial snapshot
Detailed figures (assets, liabilities, net worth) are available in the full credit report.
Officers
No officers on record.
Persons with significant control
Funding
0 funding roundsNo funding rounds on record.
Filing history
No filings match this type.
Risk at a glance
- Company active
- Accounts up to date
- Confirmation statement up to date
- No insolvency history
- No registered charges
- Credit score
- Recommended limit
- Payment risk
Get the complete credit report
- Detailed financial statements
- Credit score & payment risk
- CCJs, charges & insolvency checks
- Recommended credit limit
Secure checkout · Report delivered instantly